IR News Archives

Top
Investor Relations
IR News Archives

2025

富士製薬工業ウェブサイト、新着情報のバックナンバーです。
各新着情報の文章をクリックしていただくと、詳細情報をご覧いただけます。

latest news

2025.11.27
Other(その他): Notice of the 61th Ordinary General Meeting of Shareholders
2025.11.21
Release(リリース): Notice of Additional Approval for the indication of NextstellisTM by OLIC (Thailand) Limited
2025.11.17
Financial Results(決算資料): Script for Business Results Briefing for the Fiscal Year Ended September 30, 2025
2025.11.14
Financial Results(決算資料): Business Results of FY2025
2025.11.11
Financial Results(決算資料): Supplemental Materials of FY2025 Consolidated Financial Results
2025.11.11
Financial Results(決算資料): Financial Results of FY2025
2025.11.04
Release(リリース): Notice of Settlement and License Agreement Regarding Golimumab BS (Biosimilar)
2025.10.31
Release(リリース): Notice of Agreement Regarding Denosumab BS (Biosimilar)
2025.10.01
Release(リリース): Notice of Application for Additional Approval of indication of NextstellisTM by OLIC (Thailand) Limited
2025.09.19
Release(リリース): Marketing Approval for Three Biosimilars Aflibercept, Golimumab, Denosumab
2025.08.22
Other(その他): Corporate Report 2025 (English version) has been published
2025.08.07
Financial Results(決算資料): Supplemental Materials of 3Q/FY2025 Consolidated Financial Results
2025.08.07
Financial Results(決算資料): Financial Results of 3Q/FY2025
2025.08.01
Release(リリース): Notice Concerning Completion Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause
2025.07.25
Product(製品情報): Initiation of Phase Ⅲ clinical trial for the Alyssa® combination tablets
2025.07.17
Release(リリース): Notice Concerning Acquisition and Cancellation of the 1st Series of Stock Acquisition Rights with Exercise Price Revision Clause
2025.06.25
Product(製品情報): Emergency contraceptive pill : LEVONORGESTREL tablet 1.5 mg "F" Notice of Application for Marketing Approval as Switch OTC Drug
2025.05.15
Financial Results(決算資料): Script for 2Q Financial Results Briefing for the Fiscal Year Ending September 2025
2025.05.14
Financial Results(決算資料): Business Results of 2Q/FY2025
2025.05.08
Financial Results(決算資料): Supplemental Materials of 2Q/FY2025 Consolidated Financial Results

1
2
>

>